Liu‐Ying Luo

1.7k total citations
22 papers, 1.5k citations indexed

About

Liu‐Ying Luo is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Liu‐Ying Luo has authored 22 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 10 papers in Hematology and 8 papers in Molecular Biology. Recurrent topics in Liu‐Ying Luo's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (18 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers) and Protease and Inhibitor Mechanisms (4 papers). Liu‐Ying Luo is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (18 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers) and Protease and Inhibitor Mechanisms (4 papers). Liu‐Ying Luo collaborates with scholars based in Canada, Greece and Italy. Liu‐Ying Luo's co-authors include Eleftherios P. Diamandis, George M. Yousef, Christina V. Obiezu, Linda Grass, Andreas Scorilas, Angeliki Magklara, Antoninus Soosaipillai, David Howarth, Dionyssios Katsaros and Weiping Jiang and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and International Journal of Cancer.

In The Last Decade

Liu‐Ying Luo

21 papers receiving 1.5k citations

Peers

Liu‐Ying Luo
Maricel Gozo United States
Michelle Kuhne United States
Meaghan Wall Australia
Sean M. Post United States
Liu‐Ying Luo
Citations per year, relative to Liu‐Ying Luo Liu‐Ying Luo (= 1×) peers S. Fracchioli

Countries citing papers authored by Liu‐Ying Luo

Since Specialization
Citations

This map shows the geographic impact of Liu‐Ying Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liu‐Ying Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liu‐Ying Luo more than expected).

Fields of papers citing papers by Liu‐Ying Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liu‐Ying Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liu‐Ying Luo. The network helps show where Liu‐Ying Luo may publish in the future.

Co-authorship network of co-authors of Liu‐Ying Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Liu‐Ying Luo. A scholar is included among the top collaborators of Liu‐Ying Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liu‐Ying Luo. Liu‐Ying Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Memari, Nader, Weiping Jiang, Eleftherios P. Diamandis, & Liu‐Ying Luo. (2007). Enzymatic properties of human kallikrein-related peptidase 12 (KLK12). Biological Chemistry. 388(4). 427–435. 30 indexed citations
2.
Borgoño, Carla A., Iacovos P. Michael, Julie Shaw, et al.. (2006). Expression and Functional Characterization of the Cancer-related Serine Protease, Human Tissue Kallikrein 14. Journal of Biological Chemistry. 282(4). 2405–2422. 89 indexed citations
3.
Luo, Liu‐Ying & Weiping Jiang. (2006). Inhibition profiles of human tissue kallikreins by serine protease inhibitors. Biological Chemistry. 387(6). 813–6. 40 indexed citations
4.
Luo, Liu‐Ying, Antoninus Soosaipillai, Linda Grass, & Eleftherios P. Diamandis. (2006). Characterization of Human Kallikreins 6 and 10 in Ascites Fluid from Ovarian Cancer Patients. Tumor Biology. 27(5). 227–234. 25 indexed citations
5.
Yousef, George M., Christina V. Obiezu, Liu‐Ying Luo, et al.. (2005). Human Tissue Kallikreins: From Gene Structure to Function and Clinical Applications. Advances in clinical chemistry. 39. 11–79. 52 indexed citations
6.
Borgoño, Carla A., S. Fracchioli, George M. Yousef, et al.. (2003). Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma. International Journal of Cancer. 106(4). 605–610. 54 indexed citations
7.
Luo, Liu‐Ying, Dionyssios Katsaros, Andreas Scorilas, et al.. (2003). The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.. PubMed. 63(4). 807–11. 131 indexed citations
8.
Luo, Liu‐Ying, Linda Grass, & Eleftherios P. Diamandis. (2003). Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter. Clinica Chimica Acta. 337(1-2). 115–126. 28 indexed citations
10.
Diamandis, Eleftherios P., Akira Okui, Liu‐Ying Luo, et al.. (2002). Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma.. PubMed. 62(1). 295–300. 149 indexed citations
11.
Luo, Liu‐Ying, Antoninus Soosaipillai, & Eleftherios P. Diamandis. (2001). Molecular Cloning of a Novel Human Gene on Chromosome 4p11 by Immunoscreening of an Ovarian Carcinoma cDNA Library. Biochemical and Biophysical Research Communications. 280(1). 401–406. 18 indexed citations
12.
Luo, Liu‐Ying, Peter S. Bunting, Andreas Scorilas, & Eleftherios P. Diamandis. (2001). Human kallikrein 10: a novel tumor marker for ovarian carcinoma?. Clinica Chimica Acta. 306(1-2). 111–118. 97 indexed citations
13.
Luo, Liu‐Ying, Linda Grass, David Howarth, et al.. (2001). Immunofluorometric Assay of Human Kallikrein 10 and Its Identification in Biological Fluids and Tissues. Clinical Chemistry. 47(2). 237–246. 79 indexed citations
14.
Luo, Liu‐Ying, Dionyssios Katsaros, Andreas Scorilas, et al.. (2001). Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.. PubMed. 7(8). 2372–9. 93 indexed citations
15.
Diamandis, Eleftherios P., George M. Yousef, Liu‐Ying Luo, Angeliki Magklara, & Christina V. Obiezu. (2000). The New Human Kallikrein Gene Family: Implications in Carcinogenesis. Trends in Endocrinology and Metabolism. 11(2). 54–60. 245 indexed citations
16.
Luo, Liu‐Ying & Eleftherios P. Diamandis. (2000). Preliminary examination of time‐resolved fluorometry for protein array applications. Luminescence. 15(6). 409–413. 1 indexed citations
17.
Yousef, George M., Liu‐Ying Luo, Stephen W. Scherer, Georgia Sotiropoulou, & Eleftherios P. Diamandis. (1999). Molecular Characterization of Zyme/Protease M/Neurosin (PRSS9), A Hormonally Regulated Kallikrein-like Serine Protease. Genomics. 62(2). 251–259. 92 indexed citations
18.
Luo, Liu‐Ying & Eleftherios P. Diamandis. (1999). Amplification of human genomic DNA sequences with polymerase chain reaction using a single oligonucleotide primer. Journal of Clinical Laboratory Analysis. 13(2). 69–74. 1 indexed citations
19.
Yousef, George M., Christina V. Obiezu, Liu‐Ying Luo, Margot H. Black, & Eleftherios P. Diamandis. (1999). Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated.. PubMed. 59(17). 4252–6. 111 indexed citations
20.
Luo, Liu‐Ying, Jo-Anne Herbrick, Stephen W. Scherer, et al.. (1998). Structural Characterization and Mapping of the Normal Epithelial Cell-Specific 1 Gene. Biochemical and Biophysical Research Communications. 247(3). 580–586. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026